InterCure Ltd.

NASDAQ: INCR · Real-Time Price · USD
1.64
-0.02 (-1.20%)
At close: Aug 15, 2025, 3:57 PM
1.61
-1.83%
After-hours: Aug 15, 2025, 07:31 PM EDT

InterCure Income Statement

Financials in ILS. Fiscal year is January - December.
Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
238.85M 255.76M 272.67M 312.25M 355.55M 387.69M 414.79M 407.63M 388.68M 362.78M 323.9M 273.86M 219.68M 167.07M 127.87M 93.83M
Cost of Revenue
196.8M 195.75M 194.7M 222.46M 252.27M 256.59M 255.64M 237.49M 213.49M 199.19M 184.47M 158.1M 128.54M 96.69M 68.29M 48.7M
Gross Profit
42.05M 60.01M 77.98M 89.79M 103.28M 110.99M 139.04M 150.03M 155.08M 163.59M 139.43M 115.75M 90.53M 69.78M 58.98M 44.53M
Operating Income
-67.21M -55.01M -42.82M -42.26M -41.57M -18.37M 24.48M 36.59M 50.63M 63.15M 51.51M 42.46M 28.19M 26.59M 24.43M 14.7M
Interest Income
n/a 8.01M 16.01M 16.73M 18.26M 12M 4.16M 3.44M 3.62M 1.87M 1.71M 1.71M n/a n/a 59K 71K
Pretax Income
-87.32M -74.66M -61.99M -62.32M -61.28M -38.28M 5.4M 26.21M 43.84M 55.13M 45.26M 32.52M 18.74M 23.86M 23.98M 14.53M
Net Income
-67.8M -66.71M -65.62M -61.46M -61.96M -19.88M 20.9M 31.66M 44.82M 33.2M 24.3M 14.85M 4.69M 16.98M 20.36M 13.19M
Selling & General & Admin
110.18M 101.57M 92.97M 95.54M 98.47M 98.3M 105.82M 104.52M 97.32M 96.16M 80.94M 67.58M 57.45M 42.34M 34.19M 29M
Research & Development
414K 382.5K 351K 340.5K 388K 496K 550K 627K 632K 678K 856K 1.04M 1.24M 1.36M 1.51M 1.56M
Other Expenses
-1.33M 13.07M 27.48M 35.27M 45.1M 27.77M 6.24M 6.24M 4.2M 2.93M 2.93M 2.93M 2.93M 745K 745K 745K
Operating Expenses
109.26M 115.03M 132.98M 143.33M 156.14M 150.47M 124.34M 123.11M 113.88M 96.27M 81.22M 68.05M 58.1M 44.44M 36.44M 31.31M
Interest Expense
n/a n/a n/a 6.14M 11.84M 16.04M 20.43M 19.81M 16.4M 12.21M 10.28M 4.76M 2.55M 2.55M 330K 473K
Selling & Marketing Expenses
54.23M 53.58M 52.92M 53.43M 53.27M 19.96M 24M 24.05M 20.31M 49.43M 38.9M 29.48M 23.21M 17.73M 13.98M 10.89M
Cost & Expenses
306.05M 310.77M 327.68M 365.79M 406.37M 415.31M 388.22M 368.85M 337.65M 299.23M 269.47M 229.92M 190.26M 140.97M 104.57M 79.85M
Income Tax Expense
17.49M 11.43M 5.37M 1.31M 2.25M -13.69M -11.99M -2.93M 93K 19.68M 17.58M 14.38M 11.44M 3.3M 2.04M -497K
Shares Outstanding (Basic)
43.91M 43.91M 47.77M 47.77M 44.8M 44.8M 42.8M 42.8M 45.35M 45.35M 45.99M 37.15M 39.08M 41.1M 44.23M 27.02M
Shares Outstanding (Diluted)
43.97M 43.97M 47.77M 47.77M 44.81M 44.81M 42.8M 42.8M 45.35M 45.35M 45.99M 37.15M 42.64M 41.1M 51.6M 27.02M
EPS (Basic)
-1.55 -1.51 -1.47 -1.37 -1.39 -0.52 0.39 0.62 0.98 0.78 0.58 0.38 0.05 0.49 0.60 0.42
EPS (Diluted)
-1.55 -1.51 -1.47 -1.37 -1.39 -0.52 0.39 0.62 0.98 0.79 0.59 0.37 0.03 0.46 0.57 0.41
EBITDA
-79.33M -37.24M 5.04M 6.85M 10.3M 14.72M 38.45M 56.16M 69.56M 76.53M 63.8M 46.74M 29.65M 31.56M 30.14M 19.98M
EBIT
-87.89M -45.43M -2.97M -1.59M 737K 2.85M 25.83M 46.02M 60.24M 68.35M 56.55M 38.24M 22.26M 26.31M 25.19M 15.87M
Depreciation & Amortization
8.55M 8.18M 8.01M 9.14M 10.27M 12.57M 13.42M 12.52M 11.7M 8.28M 7.24M 6.22M 5.12M 5.26M 4.95M 4.11M